Inferring the Effects of Cancer Treatment: Divergent Results from the Early Breast Cancer Trialists’ Collaborative Group Meta-analyses of Randomized Trials.

Slides:



Advertisements
Similar presentations
San Antonio Breast Cancer Symposia Authors: Dr. Sunil Verma Date posted: January 6 th, 2008.
Advertisements

Breast Cancer Patient Issues in Family Practice: An Interactive Session.
Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.
History of the randomized evidence on early breast cancer overall survival: Radiation vs no radiation after mastectomy L. Vakaet 2006.
Role of Nodal Irradiation in Breast Cancer
An update for Illinois Nurses Elizabeth A. Peralta, MD The Breast Center at SIU Springfield, IL May 2011.
Departments - Surgery - Gerontology and Geriatrics Department of SurgeryDepartment of Gerontology & Geriatrics Prof. dr. C.J.H. van de VeldeProf. dr. R.G.J.
Memorial Sloan-Kettering Cancer Center
Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.
Intensity Modulated Radiation Therapy (IMRT) for Breast Cancer
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Hypofractionated Radiation Therapy for Early Stage Breast Cancer Patrick J. Gagnon, M.D. Resident, PGY-4 Radiation Medicine, OHSU Providence Hospital Breast.
The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,
New York University Department of Radiation Oncology A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiotherapy for Triple Negative.
Long-Term Effects of Continuing Adjuvant Tamoxifen to 10 Years versus Stopping at 5 Years After Diagnosis of Oestrogen Receptor- Positive Breast Cancer:
These slides were released by the speaker for internal use by Novartis.
Ductal Carcinoma In Situ (DCIS)
Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.
The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.
EPIB-591 Screening Jean-François Boivin 29 September
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
Radiation Breast Oncology Highlights of SABC 2006 Alison Bevan, MD PhD UCSF Radiation Oncology January, 2007.
Introduction to Systematic Reviews Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /9/20151.
CBACT: Cost Benefit Analysis for Cancer Treatments Adeeti Aggarwal Saratoga High School February 20, 2009.
A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.
Breast Cancer Risk with Menopausal Hormone Use Jackie Bouillon Advisor: Dr. Robert Hadley Spring 2007.
Evidence Based For invasive breast cancer BCT is Tumor excision, axillary node dissection, whole breast radiation Modified mastectomy is total mastectomy.
Targeted Intraoperative Radiotherapy versus Whole Breast Radiotherapy for Breast Cancer (TARGIT-A Trial): An International, Prospective, Randomised, Non-Inferiority.
Best first ? The ATAC completed treatment analysis Professor Jack Cuzick Wolfson Institute of Preventive Medicine, London, UK.
Determining Acceptable Waiting Times for the Surgical Treatment of Solid Organ Malignancies - A Systematic Review CIHR Grant: Toward Canadian Benchmarks.
HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.
San Antonio Breast Cancer Symposium 2012 Helen K. Chew, MD, FACP Professor of Medicine.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year.
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C,
Jo Anne Zujewski, MD Clinical Investigations Branch Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment May 2011 The Global Burden.
Start or Switch?: Latest data from ABCSG/ARNO
Published online July 24, Aromatase inhibitors versus tamoxifen in early breast.
 Volunteer bias  Lead time bias  Length bias  Stage migration bias  Pseudodisease.
Extended adjuvant treatment with anastrozole: results from the ABCSG Trial 6a R Jakesz, H Samonigg, R Greil, M Gnant, M Schmid, W Kwasny, E Kubista, B.
“Big Data, Better Treatment”: The work of the Early Breast Cancer Trialists’ Collaborative Group Rory Collins BHF Professor of Medicine & Epidemiology.
‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) trial: Completed Treatment Analysis.
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
Basis and Outcome of Axillary Dissection for Node Negative Axilla Gurpreet Singh Dept. Of Surgery P.G.I.M.E.R. These Power Point presentations are free.
Carboplatin Not Inferior to Radiation as Adjuvant Therapy for Stage I Seminoma Slideset on: Oliver RT, Mason MD, Mead GM, et al. Radiotherapy versus single-dose.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta- analysis of the randomised trials The Lancet Volume 386, Issue 10001,
Patterns of care and comparative effectiveness of endocrine therapy for premenopausal women with early breast cancer A multi-institution cohort study February.
MA.17R: Reduced Risk of Recurrence With Extending Adjuvant Letrozole Beyond 5 Yrs in Postmenopausal Women With Early-Stage Breast Cancer CCO Independent.
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
Prognostic significance of tumor subtypes in male breast cancer:
Local Breast Cancer Recurrence after Mastectomy and Breast-Conserving Surgery for Paget's Disease: A Meta-Analysis Breast Care 2014;9: DOI: /
Early Identification and Early Intervention
But how to treat those with positive SLNB? Results and Discussion
Kathleen England Neville Calleja 20th October 2017
Intellectual property of the EBCTCG trialists.
Volume 366, Issue 9503, Pages (December 2005)
Volume 386, Issue 10001, Pages (October 2015)
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Badwe RA et al. SABCS 2009;Abstract 72.
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials 
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient.
Relative Risk of Onset of Cancer from the Cholesterol Treatment Trialists’ (CTT) Meta-Analysis of Statin Trials, According to Year of Onset Risk ratios.
20-Year Risks of Breast-Cancer Recurrence
Published online Feb 7, 2019 Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling:
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Presentation transcript:

Inferring the Effects of Cancer Treatment: Divergent Results from the Early Breast Cancer Trialists’ Collaborative Group Meta-analyses of Randomized Trials and Observational Data from SEER Registries. Henson KE, Jagsi R, Cutter D, McGale P, Taylor C, Darby SC Journal of Clinical Oncology. Published ahead of print on January 19, doi: /JCO

Background - 1 Comparative effectiveness research is the direct comparison of existing health care interventions to determine which work best for which patients and which pose the greatest benefits and harms.

Background - 2 – As part of comparative effectiveness research, there is currently much enthusiasm for using observational data to determine the impact of cancer treatments. – eg, a literature search revealed that 58 published papers estimating the effect of radiotherapy in breast cancer had been published using just data from the SEER cancer registries. Many of these papers were in high impact journals.

Purpose of study To compare the effect of breast cancer radiotherapy, as estimated from observational data, with findings from randomized trials. Methods Selected results for 13,932 women randomised in trials included in meta-analyses by the Early Breast Cancer Trialists’ Collaborative Group were collated. Estimates of exactly the same quantities for 393,840 women with breast cancer in the US SEER cancer registries were derived. Henson et al, JCO e-pub 19 Jan 2016

Breast- conserving surgery Mastectomy in node positive disease 2p for heterogeneity EBCTCG*0.82 ( )0.84 ( )0.75 SEER Basic stratification†0.64 ( )1.34 ( )< Additional stratification‡0.63 ( )1.32 ( )< Results Breast Cancer Mortality, Radiotherapy vs No radiotherapy Ratios of annual death rates (95% Cls ) * Stratification: trial, year of follow-up, age at randomization, nodal status. † Years since breast cancer, age at breast cancer, calendar year of breast cancer, ethnicity. ‡ Additional stratification: stage, tumor size, number of involved nodes, grade, estrogen receptor status, quadrant, axillary clearance. Data from 1990 only: n=329,235. Henson et al, JCO e-pub 19 Jan 2016

Conclusions This study found strikingly divergent results between the EBCTCG randomized trial data and the SEER observational data. Efforts to remove confounding and selection biases did not diminish these differences. Non-randomized comparisons are liable to provide misleading estimates of treatment effects. Henson et al, JCO, e-pub 19 Jan 2016